Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype.

Viruses · 2023 · PMC10059835 · PMID 36992471

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

borderline significantp = 0.067so close (0.05 < p ≤ 0.1)

For the DTG group the estimated probabilities of VF were 4.8% (95% CI, 2.5–9.0%) at 1 year and 11.9% (95% CI, 6.9–20.3%) at 2 years, resulting in a borderline significant log-rank for DTG versus DRV ( p = 0.067).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.